Guangdong Jiaying Pharmaceutical Co., Ltd
Символ: 002198.SZ
SHZ
6.73
CNYПазарна цена днес
72.9972
Съотношение P/E
-0.7885
Коефициент PEG
3.42B
MRK Cap
- 0.00%
Доходност на DIV
Guangdong Jiaying Pharmaceutical Co., Ltd (002198-SZ) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1024.89 | 234.1 | 239.4 | 142.2 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 340.26 | 50.3 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.net-receivables | 839.76 | 240.6 | 175.7 | 218.5 | |||||||||||||||||||
balance-sheet.row.inventory | 338.76 | 82.3 | 73.4 | 72.8 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 6.51 | 0.4 | 1.2 | 1 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 2209.92 | 557.4 | 489.7 | 434.5 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 796.4 | 203.7 | 224.2 | 245.8 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 200.64 | 52.4 | 58.3 | 64.2 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 200.64 | 52.4 | 58.3 | 64.2 | |||||||||||||||||||
balance-sheet.row.long-term-investments | -229.76 | -20.9 | 30.6 | 58.3 | |||||||||||||||||||
balance-sheet.row.tax-assets | 8.79 | 2.2 | 4.6 | 5.6 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 343.29 | 51.8 | 0 | 0.1 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 1119.37 | 289.2 | 317.7 | 373.9 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 3329.29 | 846.7 | 807.3 | 808.4 | |||||||||||||||||||
balance-sheet.row.account-payables | 55.74 | 19 | 14.1 | 10.3 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 6.06 | 5.8 | 31.1 | 20.2 | |||||||||||||||||||
balance-sheet.row.tax-payables | 40.61 | 17.2 | 12 | 11.2 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | |||||||||||||||||||
Deferred Revenue Non Current | 1.97 | 0.5 | 0.2 | 0.2 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 138.99 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 141.6 | 47.1 | 5.7 | 3.1 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 140.95 | 35.3 | 34.9 | 35 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-liab | 363.37 | 118.2 | 122.9 | 125.4 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 2030.04 | 507.5 | 507.5 | 507.5 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 336.46 | 70.3 | 26.3 | 24.9 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 352.61 | 27.2 | 27.2 | 27.2 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 246.81 | 123.4 | 123.4 | 123.4 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 2965.92 | 728.4 | 684.5 | 683 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 3329.29 | 846.7 | 807.3 | 808.4 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-equity | 2965.92 | 728.4 | 684.5 | 683 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 3329.29 | - | - | - | |||||||||||||||||||
Total Investments | 110.5 | 29.4 | 30.6 | 58.3 | |||||||||||||||||||
balance-sheet.row.total-debt | 11.64 | 5.8 | 31.1 | 20.2 | |||||||||||||||||||
balance-sheet.row.net-debt | -672.99 | -178.1 | -208.3 | -122.1 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 46.58 | 43.9 | 1.5 | 19.8 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6.5 | 25.9 | 28.4 | 28.2 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 2.4 | 1 | -0.6 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -2.4 | -1 | 0.6 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | -94.86 | -48.4 | -4.8 | 38.8 | |||||||||||||||||||
cash-flows.row.account-receivables | -86.45 | -86.5 | 9.6 | 9 | |||||||||||||||||||
cash-flows.row.inventory | -8.41 | -8.4 | -0.8 | 2.5 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | 44.1 | -14.7 | 27.9 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 2.4 | 1 | -0.6 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 130.11 | 5.7 | 26.7 | 10 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 88.33 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -4.17 | -2.7 | -2.3 | -11.7 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 141.27 | 0.1 | 0 | 0 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -0.1 | 0 | 0 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -128.37 | 1.6 | 32.5 | 18.5 | |||||||||||||||||||
cash-flows.row.other-investing-activites | -188.54 | -49.9 | 25.1 | -25 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -179.8 | -51 | 55.2 | -18.2 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -31.1 | -15 | -135 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -0.5 | -1 | -3.8 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 31.1 | 55 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -31.6 | 15.1 | -83.8 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | -101.07 | -55.4 | 122.1 | -5.1 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 684.63 | 183.9 | 239.3 | 117.2 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 785.71 | 239.3 | 117.2 | 122.3 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 88.33 | 27.2 | 51.8 | 96.9 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -4.17 | -2.7 | -2.3 | -11.7 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 84.16 | 24.4 | 49.5 | 85.2 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 621.81 | 659.2 | 574.7 | 544.7 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 221.76 | 228.5 | 141.9 | 146.5 | |||||||||||||||||||
income-statement-row.row.gross-profit | 400.05 | 430.7 | 432.8 | 398.2 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 14.99 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 11.95 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 278.79 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 33.61 | 40.7 | 46.3 | 42.9 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 344.35 | 376 | 403.2 | 365.2 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 566.11 | 604.5 | 545.1 | 511.7 | |||||||||||||||||||
income-statement-row.row.interest-income | 4.08 | 2.3 | 2.6 | 1.1 | |||||||||||||||||||
income-statement-row.row.interest-expense | 2.31 | 0.5 | 1 | 3.7 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 278.79 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -2.94 | -2.8 | -27.8 | -1 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 33.61 | 40.7 | 46.3 | 42.9 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | -2.94 | -2.8 | -27.8 | -1 | |||||||||||||||||||
income-statement-row.row.interest-expense | 2.31 | 0.5 | 1 | 3.7 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | -2.56 | 26.6 | 28.4 | 33.5 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 52.94 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 55.5 | 53.9 | 33.6 | 24.1 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 52.56 | 51.1 | 5.8 | 23 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 5.97 | 7.2 | 4.3 | 3.2 | |||||||||||||||||||
income-statement-row.row.net-income | 46.58 | 43.9 | 1.5 | 19.8 |
Често задавани въпроси
Какво е Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) общи активи?
Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) общите активи са 846650977.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 248734345.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.166.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.166.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.075.
Какъв е общият приход на предприятието?
Общият приход е 0.089.
Каква е Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 43934703.000.
Какъв е общият дълг на фирмата?
Общият дълг е 5774011.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 375965273.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 105647839.000.